GRAIL, Inc. Common Stock
GRAL
About: GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Employees: 1,000
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
135% more call options, than puts
Call options by funds: $99.3M | Put options by funds: $42.3M
120% more capital invested
Capital invested by funds: $613M [Q1] → $1.35B (+$733M) [Q2]
80% more first-time investments, than exits
New positions opened: 74 | Existing positions closed: 41
29% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 76
10% more funds holding
Funds holding: 310 [Q1] → 341 (+31) [Q2]
2.13% more ownership
Funds ownership: 70.78% [Q1] → 72.9% (+2.13%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 3 [Q1] → 3 (+0) [Q2]
Financial journalist opinion
Based on 5 articles about GRAL published over the past 30 days
